Bill Title: A bill to require guidance on how the Food and Drug Administration will consider claims of opioid sparing and on the conditions under which the Food and Drug Administration will consider misuse and abuse of drugs in making certain determinations of safety.

Spectrum: Bipartisan Bill

Status: (Introduced - Dead) 2018-04-12 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. [SB2665 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2018-04-19	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress SB2665

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress SB2665 currently on file.

Social Comments on US SB2665